Preview Mode Links will not work in preview mode


Welcome to the Empowered Patient Podcast with Karen Jagoda.  This show is a window into the latest innovations in digital health and the changing dynamic between doctors and patients.

Topics on the show include

  • the emergence of precision medicine and breakthroughs in genomics
  • advances in biopharmaceuticals
  • age-related diseases and aging in place
  • using big data from wearables and sensors
  • transparency in the medical marketplace
  • challenges for connected health entrepreneurs

The audience includes researchers, medical professionals, patient advocates, entrepreneurs, patients, caregivers, solution providers, students, journalists, and investors.

Apr 11, 2022

Eric Adams is the CEO and President of InMed Pharmaceuticals, exploring the benefits of rare cannabinoids from the cannabis plant. We have these naturally occurring cannabinoids in our body and a number of receptors throughout our body that respond to this class of compounds. Because these rare cannabinoids exist in low quantities in the plant, they have been hard to isolate or extract, which has limited research into their therapeutic value. InMed has developed ways to economically manufacture bioidentical compounds and investigate potential benefits for treating eye and skin disorders.

Eric elaborates, "InMed Pharmaceuticals is a global leader in the manufacturing, clinical development, and commercialization of non-intoxicating, rare cannabinoids. We have two branches to the company. One is the pharmaceutical drug development program where we're taking the traditional clinical trial, FDA pathway approach to bringing important medicines to market for hard t  treat diseases. On the other hand, we also have a group that is manufacturing rare cannabinoids for the health and wellness space, so things that will be sold over the counter, such as the CBD mark t, for instance. Those two sides are joined by manufacturing know-how and a general understanding of this class of compounds that we call rare cannabinoids."

@InMedPharma #cannabinoids #rarecannabinoids #rarecannabinoid #cannabinol #CBN #glaucoma #minorcannabinoids #ophthalmology #epidermolysisbullosa #rarediseases #science #pharma

Download the transcript here